An example of IS response. Need your helps. [Bioanalytics]

posted by Shuanghe  – Spain, 2020-05-26 12:56 (355 d 10:36 ago) – Posting: # 21469
Views: 6,431

Dear All,

Recently we did a BE study and among dozens of analytical runs, there's a run where internal standard showed inconsistent response, as shown in the following figure.

[image]

I removed several double blank samples where IS responses are zero. Apart from that, all samples in the run are included, where unknown samples are from 3 subjects. IS responses of unknown and QC after around 100th injection start to climb upwards.

When asked why this run was accepted, the CRO said that the run fulfilled the criteria defined in their SOP so the run is acceptable and there is no need of repeat analysis.

Now, the product is shitty so we are far away from BE criteria. Therefore it really doesn't matter what are the true PK values for those subjects. Repeated or not, there is no way the study conclusion will be changed. New formulation will be developed.

However, from pure bioanalytical point of view, in my opinion, there's clearly something wrong here. If runs like this are deemed acceptable according to SOP and not even trig an investigation, I don't care what the creteria is, the SOP may need to be revised. At the least, the samples from 2nd half of the run should be repeated. I would repeat the whole run.

What's your opinion/experience on that? Any suggestions? Thanks.

All the best,
Shuanghe

Complete thread:

Activity
 Admin contact
21,462 posts in 4,487 threads, 1,514 registered users;
online 20 (0 registered, 20 guests [including 18 identified bots]).
Forum time: Sunday 23:32 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5